Denise M Danos1, Tekeda F Ferguson2, Neal R Simonsen1, Claudia Leonardi3, Qingzhao Yu4, Xiao-Cheng Wu5, Richard A Scribner6. 1. Stanley S. Scott Cancer Center, Louisiana State University Health-New Orleans, School of Medicine, New Orleans, LA. 2. Stanley S. Scott Cancer Center, Louisiana State University Health-New Orleans, School of Medicine, New Orleans, LA; Department of Epidemiology, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA. Electronic address: tferg4@lsuhsc.edu. 3. Stanley S. Scott Cancer Center, Louisiana State University Health-New Orleans, School of Medicine, New Orleans, LA; Department of Community and Behavioral Health, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA. 4. Stanley S. Scott Cancer Center, Louisiana State University Health-New Orleans, School of Medicine, New Orleans, LA; Department of Biostatistics, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA. 5. Department of Epidemiology, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA; Louisiana Tumor Registry, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA. 6. Stanley S. Scott Cancer Center, Louisiana State University Health-New Orleans, School of Medicine, New Orleans, LA; Department of Epidemiology, Louisiana State University Health-New Orleans, School of Public Health, New Orleans, LA.
Abstract
PURPOSE: Colorectal cancer (CRC) continues to demonstrate racial disparities in incidence and survival in the United States. This study investigates the role of neighborhood concentrated disadvantage in racial disparities in CRC incidence in Louisiana. METHODS: Louisiana Tumor Registry and U.S. Census data were used to assess the incidence of CRC diagnosed in individuals 35 years and older between 2008 and 2012. Neighborhood concentrated disadvantage index (CDI) was calculated based on the PhenX Toolkit protocol. The incidence of CRC was modeled using multilevel binomial regression with individuals nested within neighborhoods. RESULTS: Our study included 10,198 cases of CRC. Adjusting for age and sex, CRC risk was 28% higher for blacks than whites (risk ratio [RR] = 1.28; 95% confidence interval [CI] = 1.22-1.33). One SD increase in CDI was associated with 14% increase in risk for whites (RR = 1.14; 95% CI = 1.10-1.18) and 5% increase for blacks (RR = 1.05; 95% CI = 1.02-1.09). After controlling for differential effects of CDI by race, racial disparities were not observed in disadvantaged areas. CONCLUSION: CRC incidence increased with neighborhood disadvantage and racial disparities diminished with mounting disadvantage. Our results suggest additional dimensions to racial disparities in CRC outside of neighborhood disadvantage that warrants further research.
PURPOSE:Colorectal cancer (CRC) continues to demonstrate racial disparities in incidence and survival in the United States. This study investigates the role of neighborhood concentrated disadvantage in racial disparities in CRC incidence in Louisiana. METHODS: Louisiana Tumor Registry and U.S. Census data were used to assess the incidence of CRC diagnosed in individuals 35 years and older between 2008 and 2012. Neighborhood concentrated disadvantage index (CDI) was calculated based on the PhenX Toolkit protocol. The incidence of CRC was modeled using multilevel binomial regression with individuals nested within neighborhoods. RESULTS: Our study included 10,198 cases of CRC. Adjusting for age and sex, CRC risk was 28% higher for blacks than whites (risk ratio [RR] = 1.28; 95% confidence interval [CI] = 1.22-1.33). One SD increase in CDI was associated with 14% increase in risk for whites (RR = 1.14; 95% CI = 1.10-1.18) and 5% increase for blacks (RR = 1.05; 95% CI = 1.02-1.09). After controlling for differential effects of CDI by race, racial disparities were not observed in disadvantaged areas. CONCLUSION: CRC incidence increased with neighborhood disadvantage and racial disparities diminished with mounting disadvantage. Our results suggest additional dimensions to racial disparities in CRC outside of neighborhood disadvantage that warrants further research.
Authors: Thomas LaVeist; Roland Thorpe; Terra Bowen-Reid; John Jackson; Tiffany Gary; Darrell Gaskin; Dorothy Browne Journal: J Urban Health Date: 2007-11-13 Impact factor: 3.671
Authors: Jens Ludwig; Lisa Sanbonmatsu; Lisa Gennetian; Emma Adam; Greg J Duncan; Lawrence F Katz; Ronald C Kessler; Jeffrey R Kling; Stacy Tessler Lindau; Robert C Whitaker; Thomas W McDade Journal: N Engl J Med Date: 2011-10-20 Impact factor: 91.245
Authors: Amy J Schulz; Graciela Mentz; Laurie Lachance; Jonetta Johnson; Causandra Gaines; Barbara A Israel Journal: Am J Public Health Date: 2012-02-16 Impact factor: 9.308
Authors: Ashwin N Ananthakrishnan; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao Journal: Clin Gastroenterol Hepatol Date: 2014-07-17 Impact factor: 11.382
Authors: Chyke A Doubeni; Adeyinka O Laiyemo; Jacqueline M Major; Mario Schootman; Min Lian; Yikyung Park; Barry I Graubard; Albert R Hollenbeck; Rashmi Sinha Journal: Cancer Date: 2012-01-03 Impact factor: 6.860
Authors: Julie Silverman; James Krieger; Meghan Kiefer; Paul Hebert; June Robinson; Karin Nelson Journal: J Gen Intern Med Date: 2015-04-28 Impact factor: 5.128
Authors: Nancy Krieger; Jarvis T Chen; Pamela D Waterman; David H Rehkopf; S V Subramanian Journal: Am J Public Health Date: 2003-10 Impact factor: 9.308
Authors: Richard Allen Scribner; Katherine P Theall; Neal R Simonsen; Karen E Mason; Qingzhao Yu Journal: Soc Sci Med Date: 2009-10-01 Impact factor: 4.634
Authors: Astrid Steinbrecher; Kari Fish; Christina A Clarke; Dee W West; Scarlett L Gomez; Iona Cheng Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-08-21 Impact factor: 4.090
Authors: Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West Journal: BMC Med Res Methodol Date: 2022-05-19 Impact factor: 4.612
Authors: Salma Shariff-Marco; Mindy C DeRouen; Juan Yang; Jennifer Jain; David O Nelson; Margaret M Weden; Scarlett L Gomez Journal: Ann Epidemiol Date: 2021-02-10 Impact factor: 3.797
Authors: Adana A M Llanos; Jie Li; Jennifer Tsui; Joseph Gibbons; Karen Pawlish; Fechi Nwodili; Shannon Lynch; Camille Ragin; Antoinette M Stroup Journal: Front Oncol Date: 2022-04-08 Impact factor: 5.738
Authors: Kristen A Sorice; Carolyn Y Fang; Daniel Wiese; Angel Ortiz; Yuku Chen; Kevin A Henry; Shannon M Lynch Journal: Cancer Med Date: 2022-02-14 Impact factor: 4.711